Cidara Therapeutics, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€23.30K - Gross profit
-€23.30K - SG&A expenses
€21.54M - R&D expenses
€93.83M - EBITDA
-€107.07M - D&A
€169.16K - EBIT
-€110.61M - Interest expenses
€0.00 - EBT
-€101.06M - Tax expenses
€0.00 - Net income
-€78.81M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€9.53M - Changes in working capital
-€9.26M - Operating cash flow
-€111.35M - Capex
€91.48K - Other investing cash flow
€159.66K - Net investing cash flow
€68.18K - Total cash dividends paid
€0.00 - Issuance of common stock
€415.44M - Debt repayment
-€173.47K - Other financing cash flow
€267.54K - Net financing cash flow
€415.54M - Foreign exchange effects
€0.00 - Net change in cash
€304.26M - Cash at end of period
€446.11M - Free cash flow
-€111.26M
Balance sheet
- Cash and cash equivalents
€440.64M - Cash and short-term investments
€440.64M - Total receivables
€1.60M - Inventory
€0.00 - Other current assets
€16.71M - Total current assets
€458.95M - Property, plant & equipment
€2.11M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€81.99K - Total non-current assets
€2.19M - Total assets
€461.14M - Accounts payable
€1.90M - Short-term debt
€1.29M - Other current liabilities
€24.70M - Total current liabilities
€27.89M - Long-term debt
€1.44M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€721.50K - Total liabilities
€28.61M - Common stock
€1.73K - Retained earnings
-€570.00M - Other equity
€0.00 - Total equity
€432.53M - Total liabilities and shareholders' equity
€461.14M
Company information
- Market capitalization
€547.05M - Employees
38 - Enterprise Value
€170.83M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-18.2% Much better than peer group: -50.8% - ROA
-
-17.1% Much better than peer group: -69.4% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-20.4% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€2.07M